Company: OSRH
Filing Date: 2025-01-29
Form Type: S-4/A
Source: 0001213900-25-007923
Chunk: 105

Company: OSR Holdings, Inc.
Filing Date: 2025-01-29
Form: S-4/A
Chunk 105
---
 as BLAC’s Chief Financial Officer. The Sponsor additionally transferred 20,000 private placement warrants to each of Dr. Reed for his service as the former chairman of the board of directors of BLAC, Dr. Chung for his service as the former chair of the audit committee of BLAC, and Mr. Yoo for his service as BLAC’s Chief Financial Officer; •the fact that the Sponsor and BLAC’s officers and directors will lose their entire investment in BLAC and will not be reimbursed for any out -of-pocketexpenses, if any, if an initial business combination is not consummated by February14, 2025 (unless such date is extended in accordance with the Existing Governing Documents) and, as a result, the Sponsor and BLAC’s officers and directors may have a conflict of interest in determining whether OSR Holdings is an appropriate business with which to effectuate a business combination and/or in evaluating the terms of the Business Combination; •the fact that the Sponsor and BLAC’s directors and officers may be incentivized to complete the Business Combination, or an alternative initial business combination with a less favorable company or on terms less favorable to stockholders, rather than to liquidate, in which case the Sponsor would lose its entire investment, and as a result, the Sponsor may have a conflict of interest in determining whether OSR Holdings is an appropriate business with which to effectuate a business combination and/or in evaluating the terms of the Business Combination; •the fact that Sponsor has invested an aggregate of $4,325,000 (consisting of $25,000 for the founder shares, or approximately $0.014 per share, and $4,300,000 for the private placement units, or $10.00 per unit) means that the Sponsor and our officers and directors stand to make a significant profit on their investment and could potentially recoup their entire investment in BLAC even if the trading price of New OSR Holdings Common Stock after consummation of an initial business combination and after restrictions on transfer of the shares of BLAC Common Stock held by the Sponsor was as low as approximately $2.00 per share (assuming no redemptions and even if the private placement warrants and rights are worthless) and therefore our Sponsor, officers and directors may experience a positive rate of return on their investment, even if BLAC’s public stockholders experience a negative rate of return on their investment; •the fact that the Sponsor, BLAC’s officers and directors, Bellevue Capital Management LLC, or their affiliates